STAT News
AUGUST 17, 2022
National Institutes of Health failed to ensure that results of roughly half of clinical trials funded by the agency — both those conducted by its own scientists and outside researchers — were reported to a federal database during a recent two-year period, a new government review has found.
Advarra
JUNE 9, 2022
Optimizing clinical trial access for potential patients is a critical goal for researchers and sponsors. How can we make clinical research more accessible to anyone who wishes to participate? Decentralized clinical trials (DCTs) can meet that need, but they come with some challenges. Why do Funding and Sponsorship Matter?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 10, 2022
Wanting next to explore the place of research in this discussion of equity and innovation excellence, he invited Catherine Elliott to speak. And in the UK over 30% of clinical trials funded has one European partner at least. After all, cancer research is global and innovation, too, is global.
The Pharma Data
JANUARY 15, 2021
Right now, no medication is approved specifically for pulmonary hypertension caused by ILD, said Dr. Steven Nathan, senior researcher on the new trial. There are, however, drugs for another form of pulmonary hypertension, known as pulmonary arterial hypertension. Food and Drug Administration to approve Tyvaso for ILD patients.
STAT News
JANUARY 19, 2023
A Democratic lawmaker is demanding to know what steps the Food and Drug Administration and the National Institutes of Health are taking to ensure that results of clinical trials funded by the government are reported to a federal database. In a letter sent on Thursday, U.S. Frank Pallone (D-N.J.)
Expert insights. Personalized for you.
98 
Let's personalize your content